Clinical impact of de-regulated Notch-1 and Notch-3 in the development and progression of HPV-associated different histological subtypes of precancerous and cancerous lesions of human uterine cervix.

Ruby John Anto,Richa Tripathi,Suresh Bhambhani,Pallavi Singhal,Mausumi Bharadwaj,Shweta Sharma,Showket Hussain,Gayatri Rath,Poonam Jawanjal

doi:10.1371/journal.pone.0098642

Ruby John Anto, Richa Tripathi + Show 7 more

Open Access

https://doi.org/10.1371/journal.pone.0098642

Copy DOI

Abstract

BackgroundCervical cancer is the leading cause of cancer related deaths among women in India. Limited reports are available for Notch-1 and Notch-3 protein in cervical carcinoma, which play crucial role in cell proliferation, differentiation, and apoptosis.MethodsThis study was designed to evaluate the role of Notch-1 and Notch-3 with context to HPV infection in cervical carcinoma. A total of 168 tissue biopsy samples comprising of tumor specimens (n = 98), precancer (n = 30) and non-neoplastic cervical tissues (n = 40) were screened for HPV infection by PCR and expression of Notch-1 and Notch-3 protein by Immunohistochemistry and Immunoblotting.Results80% (24/30) were found to be positive for HPV in precancer and 86.7% (85/98) in cancer patients. Notch-1 expression of precancer and cancer cases was found to be significantly down-regulated with severity of disease in nuclear (3.43±0.29; 2.04±0.19, p = 0.0001, p = 0.0001) and cytoplasm (3.07±0.29; 2.29±0.17, p = 0.0001, p = 0.0001) obtained from different stages as compared to normal cervix tissue (5.40±0.19, 4.97±0.15; p<0.001; p<0.001). However, Notch-3 expression of above cases was significantly up-regulated with severity of disease and showed intense nuclear (4.17±0.39; 4.74±0.18, p = 0.0001, p = 0.0001) and cytoplasm (3.67±0.36; 4.48±0.18, p = 0.0001, p = 0.0001) of different stages as compared to normal cervix tissue (0.95±0.20, 0.70±0.20; p<0.001; p<0.001) respectively.ConclusionsThese findings suggest that Notch-1 and Notch-3 may play an important role with synergistic effect of HPV in regulating development and proliferation of cervical cancer through the deregulation of Notch signalling. This study also shows the clinical utility of both proteins which may be used as predictable biomarkers in diagnosing different histological sub-types of HPV associated cervical cancer. Nevertheless, abnormal activation of this pathway may provide legitimate targets for cervical cancer therapy.

Highlights

Cervical cancer which was the second most common female cancer worldwide in 2008 [1] is the fourth most common cancer affecting women worldwide, after breast, colorectal, and lung cancers with an incidence of about 528 000 new cases every year [2]
Ethics statement All the patients included in our study had no family history of Invasive Squamous Cell Carcinoma (ISCC) (Invasive squamous cell carcinoma) or any other disease and were not treated with chemotherapy prior to tumor removal
The study was approved by the research and ethics committee of Institute of Cytology and Preventive Oncology (ICPO)-Indian Council of Medical Research (ICMR), India

Summary

Introduction

Cervical cancer which was the second most common female cancer worldwide in 2008 [1] is the fourth most common cancer affecting women worldwide, after breast, colorectal, and lung cancers with an incidence of about 528 000 new cases every year [2]. It is the fourth most common cause of cancer death (266 000 deaths in 2012) in women worldwide [2]. Cervical cancer is the leading cause of cancer related deaths among women in India. Limited reports are available for Notch-1 and Notch-3 protein in cervical carcinoma, which play crucial role in cell proliferation, differentiation, and apoptosis

Methods

Results

Discussion

Conclusion